Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Seres Appoints Chief Commercial Officer

This article was originally published in Scrip

Executive Summary

Seres Therapeutics Inc., a microbiome therapeutics company, has appointed Wael Hashad chief commercial officer and executive vice president. Hashad has over 25 years' experience in launching therapies for companies including Amgen, Boehringer Ingelheim and Lilly. Most recently he was vice president and regional general manager at Amgen.

Advertisement
Advertisement
UsernamePublicRestriction

Register